Hyogo, Japan

Hideto Morimoto

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Jcr Pharmaceuticals Co., Ltd.. Active years: 2018-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideto Morimoto. Retrieved from https://idiyas.com/inventor/hideto-morimoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Hideto Morimoto

Introduction

Hideto Morimoto, an accomplished inventor based in Hyogo, Japan, has made significant strides in the field of biotechnology. With a total of four patents to his name, his work primarily focuses on enhancing the stability of physiologically active proteins in the human body. His latest inventions reflect a commitment to advancing medical science and improving healthcare outcomes for patients.

Latest Patents

Among Morimoto's most noteworthy patents is the development of a human serum albumin mutant. This innovative mutation can be linked to a physiologically active protein, significantly increasing the stability of that protein in the blood. The resulting protein, produced by this linking process, features a human serum albumin mutant defined by a specific amino acid sequence. Notably, the preservation of asparagine at position 318 and threonine at position 320 from the N-terminus ensures the functionality of the protein, making it a crucial advancement in the field.

Career Highlights

Hideto Morimoto currently works at JCR Pharmaceuticals Co., Ltd., where he continues to push the boundaries of medical innovation. His expertise and passion have led to significant contributions that aim to enhance therapeutic proteins, addressing various health challenges. His role at JCR Pharmaceuticals exemplifies his dedication to research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Morimoto has collaborated with esteemed colleagues, including Masafumi Kinoshita and Kenichi Takahashi. These partnerships have fostered an environment of creativity and innovation, further driving the advancement of his research projects and commercial applications.

Conclusion

Hideto Morimoto's work exemplifies the spirit of innovation in the field of biotechnology. With his groundbreaking patents and fruitful collaborations, he continues to make a lasting impact on medicine and patient care. His contributions not only enhance our understanding of protein stability but also pave the way for future advancements in therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…